ERBB2 and heart failure: Moreover, cumulative dose-dependent irreversible cardiac toxicities (such as heart failure and arrhythmia) were fatal, and combinational usage of anti-HER2 treatment may enhance the risk of heart failure (Ryberg et al., 2008).